U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Edwards SJ, Karner C, Jhita T, et al. Abrocitinib, tralokinumab and upadacitinib for treating moderate-to-severe atopic dermatitis. Southampton (UK): National Institute for Health and Care Research; 2024 Jan. (Health Technology Assessment, No. 28.04.)

Cover of Abrocitinib, tralokinumab and upadacitinib for treating moderate-to-severe atopic dermatitis

Abrocitinib, tralokinumab and upadacitinib for treating moderate-to-severe atopic dermatitis.

Show details

List of supplementary material

Supplementary material can be found on the NIHR Journals Library report page (https://doi.org/10.3310/LEXB9006).

Supplementary material has been provided by the authors to support the report and any files provided at submission will have been seen by peer reviewers, but not extensively reviewed. Any supplementary material provided at a later stage in the process may not have been peer reviewed.

Copyright © 2024 Edwards et al.

This work was produced by Edwards et al. under the terms of a commissioning contract issued by the Secretary of State for Health and Social Care. This is an Open Access publication distributed under the terms of the Creative Commons Attribution CC BY 4.0 licence, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. See: https://creativecommons.org/licenses/by/4.0/. For attribution the title, original author(s), the publication source – NIHR Journals Library, and the DOI of the publication must be cited.

Bookshelf ID: NBK600246
Contents

Views

  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (1.9M)

Other titles in this collection

Recent Activity

ClearTurn OffTurn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...